artesunic acid has been researched along with artemether in 169 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (7.10) | 18.7374 |
| 1990's | 20 (11.83) | 18.2507 |
| 2000's | 61 (36.09) | 29.6817 |
| 2010's | 56 (33.14) | 24.3611 |
| 2020's | 20 (11.83) | 2.80 |
| Authors | Studies |
|---|---|
| Lalloo, D; Trevett, A | 1 |
| Than, M; Thwe, Y; Win, K | 1 |
| Bunnag, D; Harinasuta, T; Karbwang, J; Looareesuwan, S; Viravan, C | 1 |
| Song, ZY; Zhao, KC | 1 |
| Gu, HM; Peters, W; Warhurst, DC | 1 |
| Cai, Y; Li, AY; Xie, PS; Xuan, WY; Zhao, Y | 1 |
| Feng, TG; Guo, XB; Li, GQ; Li, PS; Shi, WZ; Wang, HF; Zhang, SF | 1 |
| Du, YL; Jiang, Q; Li, CS | 1 |
| Li, ZL; Peters, W; Robinson, BL; Warhurst, DC | 1 |
| Chen, QM; Song, ZY; Zhao, KC | 1 |
| Guo, XB; Jian, HX; Jin, R; Li, GQ; Li, ZY; Wang, ZC | 1 |
| Nosten, F | 2 |
| Hien, TT | 1 |
| Looareesuwan, S | 1 |
| Liew, FY; Yang, DM | 1 |
| Angus, B; Bates, I; Krishna, S; Kyle, DE; Pipitaporn, B; Pukrittayakamee, S; Suputtamongkol, Y; Udomsangpetch, R; White, NJ | 1 |
| Davis, TM; Johnston, WA; Manning, LS; Skinner, TS | 1 |
| Brockman, A; Gathmann, I; Gemperli, B; Looareesuwan, S; Luxemburger, C; Nosten, F; Royce, C; Slight, T; van Vugt, M; White, NJ | 1 |
| Chanyakhun, P; Palananth, C; Rooney, W; Sirichaisinthop, J; Thimasarn, K | 1 |
| Newton, CR; Warrell, DA | 1 |
| Bunnag, D; Harinasuta, T; Kanda, T; Karbwang, J; Pungpak, S; Thimasarn, K | 1 |
| Angus, BJ; Nontprasert, A; Nosten-Bertrand, M; Pukrittayakamee, S; Vanijanonta, S; White, NJ | 1 |
| Brockman, A; Chongsuphajaisiddhi, T; Luxemburger, C; Nosten, F; Phaipun, L; Price, R; van Vugt, M; White, N | 1 |
| Li, Y; Wu, YL | 1 |
| Nosten, F; van Vugt, M; White, NJ | 1 |
| Chongsuphajaisiddhi, T; Kham, A; Luxemburger, C; McGready, R; Nosten, F; Phaipun, L; Price, R; Simpson, J; ter Kuile, F; van Vugt, M; White, NJ | 1 |
| Angus, BJ; Htoo, SE; Looareesuwan, S; Mann, C; Nosten, F; Poletto, C; Price, RN; Simpson, JA; Van Vugt, M; White, NJ | 1 |
| Nontprasert, A; Nosten-Bertrand, M; Pukrittayakamee, S; Vanijanonta, S; White, NJ | 1 |
| Ambroise-Thomas, P | 1 |
| Ishiyama, A; Kohana, A; Manabe, C; Omura, S; Otoguro, K; Shiomi, K; Ui, H; Yamada, H | 1 |
| Chen, M | 1 |
| Tu, Y | 1 |
| Angus, B; Keeratithakul, D; Newton, PN; Pukrittayakamee, S; Rasameesoraj, M; Suputtamongkol, Y; Teja-Isavadharm, P; White, NJ | 1 |
| Green, MD; Mount, DL; Wirtz, RA | 1 |
| Bauer, R; Efferth, T; Olbrich, A | 1 |
| Chen, XY; Duan, X; Liu, GJ; Ni, J; Qiao, JQ; Wang, Q; Wei, JF; Wu, TX; Zhang, MM; Zheng, J; Zhou, LK | 1 |
| Brittenham, GM; Gourdeuk, VR; Krudsood, S; Looareesuwan, S; Phomrattanaprapin, W; Silachamroon, U; Treeprasertsuk, S; Vannaphan, S; Wilairatana, P | 1 |
| Bégué, JP; Bonnet-Delpon, D; Crousse, B; Magueur, G; Ourévitch, M | 1 |
| Amklad, I; Looareesuwan, S; Rojanawatsirivej, C; Vijaykadga, S; Wilairatna, P | 1 |
| Bégué, JP; Bonnet-Delpon, D; Charneau, S; Crousse, B; Grellier, P; Magueur, G | 1 |
| Barihuta, T; Barutwanayo, M; Bosman, A; Ciza, A; Delacollette, C; Kamana, J; Karenzo, J; Mizero, L; Moyou-Somo, R; Nahimana, A; Ndaruhutse, J; Ndayiragije, A; Niyungeko, D; Niyungeko, E; Nyarushatsi, JP; Ringwald, P | 1 |
| Majori, G | 1 |
| Annerberg, A; Barends, M; Keola, S; Khanthavong, M; Lindegårdh, N; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; White, NJ; Yapom, R | 1 |
| Agus, C; Chiswell, GM; Chuong, LV; Davis, TM; Farrar, J; Hien, TT; Ilett, KF; Phu, NH; Sinh, DX; White, NJ | 1 |
| Annerberg, A; Christophel, EM; Dittrich, S; Jelinek, T; Lindegardh, N; Monti, F; Phetsouvanh, R; Phompida, S; Stohrer, JM; Thongpaseuth, V; Vanisaveth, V | 1 |
| Bangali, AM; Barends, M; Das, S; Faiz, AM; Kamal, M; Liem, L; Maung, UA; Peters, A; Rahman, M; Rahman, MR; van den Broek, IV | 1 |
| Garner, P; Jones, K; Taylor-Robinson, D | 1 |
| Ali, AS; Björkman, A; Gil, JP; Mårtensson, A; Montgomery, SM; Msellem, MI; Olliaro, P; Sisowath, C; Strömberg, J | 1 |
| Ashley, EA; Brockman, A; Hutagalung, R; Jelinek, T; McGready, R; Nosten, FH; Paiphun, L; Singhasivanon, P; Thwai, KL; White, NJ | 1 |
| Ahmed, OA; Elamin, SB; Eltaib, EH; Malik, EM; Mohamed, AO | 1 |
| Arbe-Barnes, S; Brun, R; Kocken, CH; Matile, H; Scheurer, C; Thomas, AW; van der Wel, A; Wittlin, S | 1 |
| Chiswell, GM; Dabod, E; Davis, TM; Hamzah, J; Ilett, KF; Karunajeewa, HA; Lorry, K; Page-Sharp, M; Reeder, J | 1 |
| Balkan, S; Checchi, F; Guerin, PJ; Guthmann, JP; Pinoges, L; Rolland, E | 1 |
| Keiser, J; Shu-Hua, X; Tanner, M; Utzinger, J | 1 |
| Alaribe, A; Ejemot, R; Ekenjoku, J; Ezedinachi, E; Meremikwu, M; Nwachukwu, C; Ordu, D; Oyo-Ita, A | 1 |
| Balkan, S; Cohuet, S; Fortes, F; Francis, M; Guthmann, JP; Kiguli, J; Kyomuhendo, J; Mulemba, M; Noël, F; Rigutto, C; Saraiva, N | 1 |
| Ahmed, ES; Elamin, SB; Elhassan, AH; Elmardi, KA; Malik, EM; Mannan, AA; Mohamed, TA; Mowien, RM | 1 |
| Garner, P; Omari, A | 1 |
| Jian, X; Keiser, J; Odermatt, P; Shu-Hua, X; Tanner, M; Tesana, S; Utzinger, J; Zhen-San, C | 1 |
| Chappuis, F; Jackson, Y; Loutan, L; Taylor, W | 1 |
| Dicko, A; Djimde, A; Doumbo, OK; Fofana, M; Guindo, O; Jansen, HF; Kone, M; Ouattara, A; Sagara, I; Sissoko, M; Sogoba, M; Thera, MA; Tolo, Y | 1 |
| Al Attas, S; Balasegaram, M; Guthmann, JP; Kitz, C; Libama, F; van den Broek, I | 1 |
| Atemnkeng, MA; De Cock, K; Plaizier-Vercammen, J | 1 |
| Chekem, L; Wierucki, S | 1 |
| Cravo, P; do Rosário, VE; Ferreira, C; Ferreira, ID; Lopes, D; Martinelli, A | 1 |
| Checkley, AM; Whitty, CJ | 1 |
| Davis, TM; Ilett, KF; Karunajeewa, HA; Manning, L; Mueller, I | 1 |
| Dokomajilar, C; Dorsey, G; Joloba, M; Nsobya, SL; Rosenthal, PJ | 1 |
| Dieng, Y; Faye, B; Faye, O; Gaye, O; Ndiaye, D; Ndiaye, JL | 1 |
| Keiser, J; Morson, G | 1 |
| Nyunt, MM; Plowe, CV | 1 |
| Cravo, P; do Carmo, EL; do Rosário, VE; Ferreira, ID; Martinelli, A; Póvoa, MM; Rodrigues, LA | 1 |
| Ademowo, OG; Falade, CO; Ladipo, SM; Ogundele, AO; Yusuf, BO | 1 |
| Kalinda, AS; Maio, WA; Posner, GH | 1 |
| Adjuik, M; Amenga-Etego, S; Asante, KP; Chandramohan, D; Dosoo, DK; Greenwood, B; Gyapong, J; Owusu, R; Owusu-Agyei, S | 1 |
| Ashley, EA; Balkan, S; Bukirwa, H; Checchi, F; Dorsey, G; Guthmann, JP; Olliaro, P; Pinoges, L; Taylor, WR; Turyakira, E; Urruta, PP; van den Broek, I; van Herp, M; Zongo, I | 1 |
| Clark, RL; Cox, EM; Gristwood, WE; Lerman, SA; White, TE | 1 |
| Hou, J; Wang, D; Wang, H; Zhang, R | 1 |
| Coulibaly, M; Diallo, A; Diawara, SI; Dicko, A; Djimde, A; Doumbo, OK; Guindo, O; Kone, M; Maiga, H; Niambele, MB; Sagara, I; Sissoko, M | 1 |
| Davis, TM; Gomorrai, PS; Griffin, S; Ilett, KF; Karunajeewa, HA; Kotab, K; Lautu, D; Law, I; Lin, E; Mueller, I; Oa, O; Page-Sharp, M; Salman, S; Senn, M; Siba, P; Suano, P; Tarongka, N; Ura, A; Wong, R | 1 |
| Keiser, J; Liu, XY; Qiang, HQ; Tanner, M; Utzinger, J; Xiao, SH; Xue, J; Zhang, YN | 1 |
| Ashley, EA; Barends, M; Keereecharoen, L; Laochan, N; Lindegardh, N; McGready, R; Nosten, F; Phaiphun, L; Pimanpanarak, M; Singhasivanon, P; Tan, SO; Viladpai-Nguen, J; White, NJ; Wüstefeld, K | 1 |
| Campagna, AM; Patnaik, MM | 1 |
| Wu, ZX; Xiao, SH; Xue, J | 1 |
| Keiser, J; Smith, TA; Utzinger, J; Xiao, SH | 1 |
| Amos, B; Hendriksen, I; Mandea, V; Manjurano, A; Mapunda, E; Mrema, H; Mtove, G; Reyburn, H; Rutta, B; Sykes, A; Whitty, CJ | 1 |
| Hong, SJ; Hong, ST; Keiser, J; Kim, TI; Li, S; Yoo, WG | 1 |
| Annerberg, A; Aweeka, F; Clark, TD; Dorsey, G; Drysdale, T; German, P; Kalyango, JN; Kamya, MR; Lindegardh, N; McGee, B; Mwesigwa, J; Parikh, S; Rosenthal, PJ | 1 |
| Kilby, G; Kraml, C; Lynam, KG; Mrozinski, P; Pelczer, I; Stringham, RW | 1 |
| Faye, B; Gaye, O; Gueye, A; Lô, AC; Ndiaye, JL; Sylla, K; Tine, R | 1 |
| Efferth, T; Kaina, B | 1 |
| Chau, TT; Chuong, LV; Day, N; Farrar, J; Hien, TT; Mai, NT; Phu, NH; Sinh, DX; Tuan, PQ; White, NJ | 1 |
| Keiser, J; Vargas, M | 1 |
| Nosten, FH | 1 |
| Bedu-Addo, G; Bhatt, KM; Borghini-Fuhrer, I; Bustos, DG; Duparc, S; Fleckenstein, L; Gaye, O; Kayentao, K; Sesay, SS; Shin, CS; Thompson, R; Tjitra, E; Tshefu, AK | 1 |
| Akter, J; Haque, R; Khan, WA; Ley, B; Marma, AS; Noedl, H; Starzengruber, P; Swoboda, P; Thriemer, K; Vossen, MG | 1 |
| Clark, TD; Dorsey, G; Greenhouse, B; Kamya, MR; Maiteki-Sebuguzi, C; Njama-Meya, D; Nzarubara, B; Rosenthal, PJ; Staedke, SG | 1 |
| Jiao, PY; Mei, JY; Xiao, SH | 1 |
| Bai, KH; Liu, T; Wang, RL; Xing, J; Zhang, LF; Zhang, SQ | 1 |
| Carvalho, LJ; Clemmer, L; Frangos, JA; Martins, YC; Zanini, GM | 1 |
| Duthaler, U; Huwyler, J; Keiser, J | 1 |
| Cochupanachimootil, J; Harris, P; Norton, R; Price, S; Senthuran, S | 1 |
| Dai, JR; Li, HJ; Li, YZ; Liang, YS; Qu, GL; Tao, YH; Wang, W; Wei, JY; Xing, YT | 1 |
| Anstey, NM; Chan, L; Donaldson, S; Frederick, C; Jelip, J; Khoo, S; Ma, G; Menon, J; Rajahram, G; William, T; Yeo, TW | 1 |
| Qiang, HQ; Xiao, SH; Xu, LL; Xue, J; Zhang, YN | 1 |
| Cringoli, G; Duthaler, U; Huwyler, J; Keiser, J; Rinaldi, L | 1 |
| Joshi, M; Pathak, S; Patil, S; Patravale, V; Sharma, S | 1 |
| Kusriastuti, R; Surya, A | 1 |
| El-Duah, M; Ofori-Kwakye, K | 1 |
| George, LB; Jasrai, YT; Kumar, SP; Pandya, HA; Patel, SK | 1 |
| Cui, L; Cui, Y; Wang, B; Wang, M; Yan, G; Zhou, G | 1 |
| Burkholder, B; Bustos, MD; Delacollette, C; Wongsrichanalai, C | 1 |
| Dai, JR; Ji, Y; Li, HJ; Li, TY; Liang, YS; Qian, YL; Qu, GL; Wang, W | 1 |
| Ashton, M; Ericsson, T; Hoffmann, KJ; Sundell, J; Torkelsson, A | 1 |
| Agrawal, R; Khatri, PC; Kochar, DK; Lahoti, A; Tanwar, GS; Tanwar, P | 1 |
| Li, GX; Wang, W; Wang, YH; Xu, FL; Zhang, XG; Zhao, SS | 1 |
| Ding, RG; Dong, YS; Gao, XX; Guan, YB; Han, G; Jing, SF; Qu, WS; Wang, HM; Wang, QJ; Yin, JY; Yuan, Y; Zhao, KY | 1 |
| Batty, KT; Senarathna, SM | 1 |
| Effa, EE; Esu, E; Meremikwu, MM; Opie, ON; Uwaoma, A | 1 |
| Corsello, MA; Garg, NK | 1 |
| Wang, FY; Wang, YB; Wei, DD; Wei, YB; Yin, B; Yu, ZH; Zhang, BG; Zhao, GH | 1 |
| Brennan, GP; Fairweather, I; Halferty, L; Hanna, RE; Johnston, RC; O'Neill, JF | 2 |
| Bertinaria, M; Carvalho, LJ; Frangos, JA; Fruttero, R; Gasco, A; Guglielmo, S; Hofer, A; Marini, E; Martins, YC; Orjuela-Sanchez, P; Zanini, GM | 1 |
| Colak, M; Efferth, T; Elmasaoudi, K; Greten, HJ; Janah, R; Kadioglu, O; Ooko, E; Saeed, ME; Sarvi, S | 1 |
| Bonfill, M; Cusido, RM; Dilshad, E; Mirza, B; Ramirez Estrada, K | 1 |
| Efferth, T; Greten, HJ; Kremsner, PG; Krishna, S; Saeed, MEM | 1 |
| Beteck, RM; Birkholtz, LM; Coertzen, D; Haynes, RK; N'Da, DD; Smit, FJ | 1 |
| Ackermann, I; Aubin, F; Carn, G; Gesase, S; Lusingu, JPA; Mnkande, E; Mrango, Z; Mtoro, A; Ngocho, JS; Ogutu, B; Onyango, KO; Ouedraogo, A; Sirima, SB; Strub, N; Vanraes, J; Yaro, JB | 1 |
| Awano, T; Baba, ES; Batisso, E; Edossa, W; Getachew, D; Hamade, P; Kebede, Z; Kefyalew, T; Mekonnen, E; Mukanga, D; Nankabirwa, JI; Shumba, C; Tekalegne, A; Tibenderana, J | 1 |
| Sullivan, DJ; Walker, LA | 1 |
| Amran, JG; Arale, AM; Barrette, A; Hassan, AH; Hassan, AM; Jibril, AM; Mohamud, SA; Muse, AY; Nada, RA; Warsame, M; Yusuf, FE | 1 |
| Hasegawa, C; Kimura, M; Kudo, M; Maruyama, H | 1 |
| Efferth, T; Naß, J | 1 |
| Aydin-Schmidt, B; Björkman, A; Di Santi, S; Inoue, J; Islam, A; Jovel, I; Mårtensson, A; Morris, U; Segurado, AC | 1 |
| Dias, S; Donegan, S; Welton, NJ | 1 |
| Amara, A; Byakika-Kibwika, P; Chiong, J; Else, L; Gini, J; Kaboggoza, J; Khoo, SH; Lamorde, M; Tarning, J; Waitt, C; Walimbwa, SI; Winterberg, M | 1 |
| Banda, CG; Barnes, KI; Maartens, G | 1 |
| Amara, A; Khoo, S; Lamorde, M; Waitt, C; Walimbwa, S | 1 |
| Effa, EE; Esu, EB; Meremikwu, MM; Opie, ON | 1 |
| Abdel-Muhsin, AA; Abdelraheem, MH; Al Dhuhli, A; Al Hosni, A; Al Rubkhi, M; Al-Hamidhi, S; Babiker, HA; Bakhiet, AMA; Gadalla, A; Gismelseed, L; Kheir, A; Mukhtar, M; Naiem, A; Omer, S; Sultan, AA | 1 |
| Obiebi, IP | 1 |
| Fungula, B; Inocencio da Luz, R; Kalabuanga, M; Lula Ntamba, Y; Lutumba, P; Muhindo Mavoko, H; Ntamabyaliro Nsengi, PM; Tona Lutete, G; Van Geertruyden, JP | 1 |
| Atusiimirwe, JK; Ayikobua, ET; Kalange, M; Kasolo, J; Kasozi, KI; Matama, K; Munanura, EI; Namulema, J; Nansunga, M; Okpanachi, AO; Semuyaba, I; Ssempijja, F; Zirintunda, G | 1 |
| Gille, L; Machín, L; Monzote, L; Nápoles, R | 1 |
| Al Khaja, KAJ; Sequeira, RP | 1 |
| Denti, P; Kawuma, AN; Khoo, S; Lamorde, M; Pillai, GC; Walimbwa, SI; Wasmann, RE | 1 |
| Alessandri, F; Angeletti, S; Bazzardi, R; Ceccarelli, G; Celani, L; Ciccozzi, M; D'Ettorre, G; De Angelis, M; Fontanelli Sulekova, L; Gabrielli, S; Lopalco, M; Mattiucci, S; Mazzocato, V; Pugliese, F; Ruberto, F; Spagnolello, O; Vita, S | 1 |
| Bancone, G; Carrara, VI; Chu, C; Duanguppama, J; Gilder, ME; Haohankhunnatham, W; Imwong, M; Konghahong, K; Lee, SJ; McGready, R; Min, AM; Nosten, F; Paw, MK; Phyo, AP; Pimanpanarak, M; Proux, S; Saito, M; Singhasivanon, P; Tun, NW; Turner, C; Viladpai-Nguen, J; White, NJ | 1 |
| An, X; Fan, H; Hu, Y; Lin, H; Liu, M; Qin, H; Shi, Z; Song, L; Tong, Y; Yang, X | 1 |
| Jiang, Z; Qiao, S; Sun, F; Zhang, H | 1 |
| Aboh, PM; Adzemye, LM; Akam, LF; Ali, IM; Alifrangis, M; Ambani, MCE; Ango, Z; Bigoga, JD; Chedjou, JPK; Dinza, G; Dongmo, CH; Douanla, A; Ewane, MS; Fomboh, CT; Fosah, DA; Kotcholi, GB; Ludovic, AJ; Mbacham, WF; Moyeh, MN; Nana, WD; Ndikum, VN; Ngu, JA; Niba, PTN; Nji, AM; Nna, DRA; Oben, OLA; Omgba, PAM; Selly-Ngaloumo, AA; Tatah, FM; Ticha, JT | 1 |
| Baraka, V; Kamugisha, E; Kapesa, A; Kidenya, B; Konje, E; Marwa, K; Mukonzo, J; Swedberg, G | 1 |
| Asinya, M; Jeuronlon, MK; Kamara, P; Koko, VS; Kollie, A; Ma, L; Menard, D; Nyansaiye, P; Parwon, S; Pratt, OJ; Ringwald, P; Taweh, F; Tehmeh, L; Vonhm, B; Warsame, M | 1 |
| Basco, LK; Briolant, S; Casimiro, PN; Kobawila, SC; Matondo Diassivi, B; Ndounga, M; Pembet Singana, B; Ringwald, P; Youndouka, JM | 1 |
| Grundmann, O; Hernandez Maldonado, J | 1 |
| Baguiya, A; Barry, N; Hien, D; Kaboré, JMT; Siribié, M; Sirima, SB; Soulama, I; Tchouatieu, AM; Tiono, AB | 1 |
| Amoh, G; Amuzu, DSY; Andoh, NE; Ansong, M; Hirst, J; Nyaaba, N; Ordóñez-Mena, JM | 1 |
| Adegnika, AA; Akinosho, MA; Davi, SD; Dimessa-Mbadinga, LB; Handrich, C; Kreidenweiss, A; Kremsner, PG; Lell, B; Mombo-Ngoma, G; Ndzebe-Ndoumba, WF; Nordmann, T; Okwu, DG; Ramharter, M; Stelzl, D; Veletzky, L; Zoleko-Manego, R | 1 |
| Andrianaranjaka, VHI; Dodoson, BT; Fenomanana, J; Rakotoarisoa, MA; Ratsimbasoa, A | 1 |
| Chen, Y; Cheng, Y; Li, P; Liu, H; Lu, X; Ma, Y; Song, C; Wang, Y; Zhang, Z | 1 |
| Mace, KE; Schultz, JS; Tan, KR | 1 |
| Abdelkader, O; Boulotigam, K; Djimadoum, M; Djimrassengar, H; Doderer-Lang, C; Hassoumi, M; Issa, AH; Issa, MS; Mahamat, MHT; Menard, D; Ndihiokubwayo, JB; Rasmussen, C; Saleh, IDM; Warsame, M | 1 |
29 review(s) available for artesunic acid and artemether
| Article | Year |
|---|---|
A new look at an old drug: artemesinin and qinghaosu.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Humans; Malaria, Cerebral; Malaria, Falciparum; Sesquiterpenes | 1992 |
Studies of qinghaosu and its active derivatives in biological materials and their pharmacokinetics.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Sesquiterpenes; Structure-Activity Relationship | 1989 |
An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Viet Nam.
Topics: Adolescent; Adult; Antimalarials; Antiprotozoal Agents; Artemether; Artemisinins; Artesunate; Clinical Trials as Topic; Double-Blind Method; Drug Resistance; Humans; Malaria, Falciparum; Middle Aged; Sesquiterpenes; Vietnam | 1994 |
Overview of clinical studies on artemisinin derivatives in Thailand.
Topics: Antimalarials; Antiprotozoal Agents; Artemether; Artemisinins; Artesunate; Clinical Trials as Topic; Drug Resistance; Humans; Malaria, Falciparum; Sesquiterpenes; Thailand | 1994 |
Neurological manifestations of falciparum malaria.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Humans; Malaria, Cerebral; Quinidine; Quinine; Sesquiterpenes | 1998 |
How Chinese scientists discovered qinghaosu (artemisinin) and developed its derivatives? What are the future perspectives?
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Drug Evaluation; Drug Resistance; Forecasting; Humans; Malaria, Falciparum; Medicine, Chinese Traditional; Sesquiterpenes | 1998 |
Intrarectal artemisinin derivatives.
Topics: Absorption; Administration, Rectal; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Humans; Malaria; Metabolic Clearance Rate; Sesquiterpenes; Suppositories | 1998 |
Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives.
Topics: Acute Disease; Antimalarials; Artemether; Artemisinins; Artesunate; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Sesquiterpenes | 1999 |
[Treatment of malaria: prevention of resistance by combinations of antimalarial agents].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Naphthyridines; Plasmodium; Sesquiterpenes | 2000 |
Progress in schistosomiasis control in China.
Topics: Animals; Artemether; Artemisinins; Artesunate; China; Humans; Prevalence; Schistosomiasis japonica; Schistosomicides; Sesquiterpenes | 1999 |
[Systematic review of benefits and harms of artemisinin-type compounds for preventing schistosomiasis].
Topics: Adult; Artemether; Artemisinins; Artesunate; Double-Blind Method; Female; Humans; Male; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Schistosomiasis japonica; Schistosomicides; Sesquiterpenes | 2003 |
[Combined antimalarial therapy using artemisinin].
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Doxycycline; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Plasmodium; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2004 |
Malaria: uncomplicated, caused by Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Proguanil; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2005 |
Malaria: severe, life threatening.
Topics: Acute Disease; Antimalarials; Artemether; Artemisinins; Artesunate; Humans; Malaria; Quinine; Sesquiterpenes | 2006 |
Artesunate, artemether or quinine in severe Plasmodium falciparum malaria?
Topics: Animals; Artemether; Artemisinins; Artesunate; Humans; Malaria, Falciparum; Quinine; Sesquiterpenes | 2007 |
Rectal administration of artemisinin derivatives for the treatment of malaria.
Topics: Administration, Rectal; Area Under Curve; Artemether; Artemisinins; Artesunate; Humans; Malaria; Sesquiterpenes | 2007 |
[Experimental study progress on tribendimidine, artemether and artesunate against Clonorchis sinensis and other trematodes].
Topics: Animals; Anthelmintics; Artemether; Artemisinins; Artesunate; Clonorchiasis; Clonorchis sinensis; Cricetinae; Dogs; Phenylenediamines; Rats; Trematoda; Trematode Infections | 2009 |
Toxicity of the antimalarial artemisinin and its dervatives.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Clinical Trials as Topic; Developing Countries; Dogs; Drug Administration Routes; Drug-Related Side Effects and Adverse Reactions; Humans; Malaria; Rabbits; Rats; Sesquiterpenes | 2010 |
Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Quinolines | 2013 |
A review of dihydroartemisinin as another gift from traditional Chinese medicine not only for malaria control but also for schistosomiasis control.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drugs, Chinese Herbal; Female; Malaria, Falciparum; Mice; Praziquantel; Schistosomiasis japonica; Schistosomicides | 2014 |
Artemether for severe malaria.
Topics: Adolescent; Adult; Africa; Antimalarials; Artemether; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Humans; Infant; Injections, Intramuscular; Malaria, Cerebral; Malaria, Falciparum; Oceania; Quinine; Randomized Controlled Trials as Topic | 2014 |
Synthetic chemistry fuels interdisciplinary approaches to the production of artemisinin.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Drug Resistance, Microbial; Malaria; Molecular Structure; Plasmodium falciparum | 2015 |
Antischistosomal activity of artemisinin derivatives in vivo and in patients.
Topics: Animals; Artemether; Artemisinins; Artesunate; Female; Humans; Male; Parasite Egg Count; Schistosoma; Schistosomiasis; Schistosomicides; Treatment Outcome | 2016 |
The activity of Artemisia spp. and their constituents against Trypanosomiasis.
Topics: Antimalarials; Artemether; Artemisia; Artemisinins; Artesunate; Oils, Volatile; Phytochemicals; Plant Extracts; Scopoletin; Trypanosomiasis | 2018 |
Artemether for severe malaria.
Topics: Adolescent; Adult; Africa; Age Factors; Antimalarials; Artemether; Artesunate; Asia; Child; Child, Preschool; Coma; Fever; Humans; Infant; Injections, Intramuscular; Malaria, Cerebral; Malaria, Falciparum; Oceania; Quinine; Randomized Controlled Trials as Topic; Treatment Outcome | 2019 |
Drug treatment and prevention of malaria in pregnancy: a critical review of the guidelines.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Chloroquine; Drug Combinations; Female; Humans; Malaria; Parasitemia; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinine; Sulfadoxine | 2021 |
Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis.
Topics: Africa South of the Sahara; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Humans; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines | 2022 |
Drug-Drug Interactions of Artemisinin-Based Combination Therapies in Malaria Treatment: A Narrative Review of the Literature.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum | 2022 |
Comparative efficacy and safety of the artemisinin derivatives compared to quinine for treating severe malaria in children and adults: A systematic update of literature and network meta-analysis.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Humans; Malaria, Cerebral; Malaria, Falciparum; Network Meta-Analysis; Quinine | 2022 |
43 trial(s) available for artesunic acid and artemether
| Article | Year |
|---|---|
Comparison of combinations of parenteral artemisinin derivatives plus oral mefloquine with intravenous quinine plus oral tetracycline for treating cerebral malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Humans; Malaria, Cerebral; Mefloquine; Middle Aged; Prospective Studies; Quinine; Sesquiterpenes; Tetracycline | 1992 |
Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand. A preliminary report.
Topics: Administration, Oral; Adolescent; Adult; Artemether; Artemisinins; Artesunate; Drug Administration Schedule; Drug Resistance; Hospitals, University; Humans; Injections, Intramuscular; Injections, Intravenous; Leukopenia; Malaria, Falciparum; Male; Microbial Sensitivity Tests; Recurrence; Sesquiterpenes; Thailand | 1991 |
Antimalarial efficacy and mode of action of qinghaosu and its derivatives in experimental models. China Cooperative Research Group on qinghaosu and its derivatives as antimalarials.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Erythrocytes; Malaria; Mice; Multicenter Studies as Topic; Plasmodium; Sesquiterpenes | 1982 |
Metabolism and pharmacokinetics of qinghaosu and its derivatives. China Cooperative Research Group on qinghaosu and its derivatives as antimalarials.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Biological Availability; Biotransformation; Multicenter Studies as Topic; Rabbits; Rats; Sesquiterpenes; Tissue Distribution | 1982 |
Studies on the toxicity of qinghaosu and its derivatives. China Cooperative Research Group on qinghaosu and its derivatives as antimalarials.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Dogs; Female; Guinea Pigs; Macaca mulatta; Male; Mice; Multicenter Studies as Topic; Mutagenicity Tests; Rabbits; Rats; Rats, Inbred Strains; Sesquiterpenes | 1982 |
Clinical studies on the treatment of malaria with qinghaosu and its derivatives. China Cooperative Research Group on qinghaosu and its derivatives as antimalarials.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Humans; Malaria; Multicenter Studies as Topic; Plasmodium falciparum; Plasmodium vivax; Sesquiterpenes | 1982 |
Artemisinin: large community studies.
Topics: Administration, Oral; Antimalarials; Antiprotozoal Agents; Artemether; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Prospective Studies; Sesquiterpenes; Suppositories | 1994 |
Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Double-Blind Method; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Prospective Studies; Sesquiterpenes; Treatment Outcome | 1998 |
A comparative study of artesunate and artemether in combination with mefloquine on multidrug resistant falciparum malaria in eastern Thailand.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Thailand; Treatment Outcome | 1997 |
Two doses of artemether/mefloquine or artesunate/mefloquine combination for multidrug resistant falciparum Malaria.
Topics: Acute Disease; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Thailand; Treatment Outcome | 1997 |
Artesunate versus artemether for the treatment of recrudescent multidrug-resistant falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Resistance, Multiple; Female; Humans; Infant; Malaria, Falciparum; Male; Recurrence; Sesquiterpenes; Treatment Failure | 1998 |
A comparison of oral artesunate and artemether antimalarial bioactivities in acute falciparum malaria.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Antimalarials; Area Under Curve; Artemether; Artemisinins; Artesunate; Biological Availability; Cross-Over Studies; Female; Humans; Malaria, Falciparum; Male; Models, Biological; Sesquiterpenes; Thailand; Time Factors | 2001 |
Monitoring the therapeutic efficacy of antimalarials against uncomplicated falciparum malaria in Thailand.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Health Policy; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Middle Aged; Primaquine; Sesquiterpenes; Statistics, Nonparametric; Thailand; Treatment Outcome | 2003 |
Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Laos; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2004 |
Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Gas Chromatography-Mass Spectrometry; Half-Life; Humans; Injections, Intramuscular; Malaria, Falciparum; Middle Aged; Sesquiterpenes; Vietnam | 2004 |
Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Biological Availability; Child; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Korea; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Sesquiterpenes; Treatment Outcome | 2004 |
Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Artesunate; Bangladesh; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2005 |
Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Odds Ratio; Plasmodium falciparum; Sesquiterpenes; Tanzania | 2005 |
A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Thailand | 2005 |
Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Body Weight; Child; Child, Preschool; Clinical Trials as Topic; Developing Countries; Endemic Diseases; Female; Humans; Infant; Injections, Intramuscular; Malaria, Falciparum; Male; Papua New Guinea; Parasitemia; Retrospective Studies; Sesquiterpenes; Severity of Illness Index; Suppositories | 2006 |
Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome | 2006 |
High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola.
Topics: Amodiaquine; Angola; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Sesquiterpenes; Treatment Outcome | 2006 |
A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali.
Topics: Adolescent; Adult; Anemia; Antimalarials; Artemether; Artemisinins; Artesunate; Carrier State; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sesquiterpenes; Sulfalene; Treatment Outcome | 2006 |
Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Democratic Republic of the Congo; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome | 2006 |
Artesunate, artemether or quinine in severe Plasmodium falciparum malaria?
Topics: Animals; Artemether; Artemisinins; Artesunate; Humans; Malaria, Falciparum; Quinine; Sesquiterpenes | 2007 |
Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda.
Topics: Alleles; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Sesquiterpenes; Treatment Outcome; Uganda | 2007 |
Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Infant; Lumefantrine; Malaria, Falciparum; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Senegal; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
High efficacy of two artemisinin-based combinations (artemether-lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, Nigeria.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Treatment Outcome | 2008 |
An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Dapsone; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Male; Polymerase Chain Reaction; Proguanil; Treatment Outcome | 2008 |
A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Base Sequence; DNA Primers; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mali; Mefloquine; Plasmodium falciparum; Polymerase Chain Reaction; Treatment Outcome | 2008 |
A trial of combination antimalarial therapies in children from Papua New Guinea.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Kaplan-Meier Estimate; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Male; Proportional Hazards Models; Pyrimethamine; Quinolines; Recurrence; Sulfadoxine | 2008 |
A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
Topics: Adult; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Thailand; Young Adult | 2008 |
Azithromycin plus artesunate versus artemether-lumefantrine for treatment of uncomplicated malaria in Tanzanian children: a randomized, controlled trial.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Azithromycin; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fever of Unknown Origin; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Male; Tanzania; Treatment Outcome | 2009 |
A randomized trial of artesunate mefloquine versus artemether lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Senegalese children.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Base Sequence; Child; Child, Preschool; DNA Primers; Female; Humans; Malaria, Falciparum; Male; Polymerase Chain Reaction | 2010 |
Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Cause of Death; Double-Blind Method; Female; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Logistic Models; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Severity of Illness Index; Treatment Outcome; Vietnam; Young Adult | 2010 |
Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
Topics: Adolescent; Adult; Africa; Antimalarials; Artemether; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Double-Blind Method; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Naphthyridines; Treatment Outcome; Young Adult | 2010 |
Azithromycin combination therapy for the treatment of uncomplicated falciparum malaria in Bangladesh: an open-label randomized, controlled clinical trial.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Azithromycin; Bangladesh; Child; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Time Factors; Treatment Outcome; Young Adult | 2010 |
Incidence of malaria and efficacy of combination antimalarial therapies over 4 years in an urban cohort of Ugandan children.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Incidence; Infant; Lumefantrine; Malaria; Male; Pyrimethamine; Sulfadoxine; Treatment Outcome; Uganda | 2010 |
Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial.
Topics: Africa South of the Sahara; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Patient Safety; Polymerase Chain Reaction | 2016 |
A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Mefloquine; Myanmar; Pregnancy; Premature Birth; Quinolines; Thailand | 2021 |
Effectiveness and safety of artesunate-amodiaquine versus artemether-lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6-120 months in Yaoundé, Cameroon: a randomized trial.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Cameroon; Child; Drug Combinations; Ethanolamines; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Treatment Outcome | 2022 |
Effectiveness of antimalarial drug combinations in treating concomitant urogenital schistosomiasis in malaria patients in Lambaréné, Gabon: A non-randomised event-monitoring study.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Drug Combinations; Ethanolamines; Gabon; Humans; Malaria; Malaria, Falciparum; Schistosomiasis haematobia | 2022 |
Comparative effect of artemether-lumefantrine and artesunate-amodiaquine on gametocyte clearance in children with uncomplicated Plasmodium falciparum malaria in Madagascar.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Child, Preschool; Drug Combinations; Ethanolamines; Humans; Infant; Madagascar; Malaria, Falciparum; Plasmodium falciparum | 2022 |
98 other study(ies) available for artesunic acid and artemether
| Article | Year |
|---|---|
Hemolysis induced by artemisinin and its derivatives in vitro.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Erythrocytes; Hemoglobins; Hemolysis; Humans; Pyrans; Sesquiterpenes | 1986 |
Experimental studies on the antimalarial activity estimation by artesunate and artemether preparations per skin absorption.
Topics: Administration, Cutaneous; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Female; Malaria; Male; Mice; Plasmodium berghei; Sesquiterpenes; Skin Absorption | 1988 |
[Clinical study on the treatment of malaria with artemether and artesunate].
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Humans; Malaria; Plasmodium falciparum; Plasmodium vivax; Pyrans; Recurrence; Sesquiterpenes | 1988 |
[Development of a qinghaosu-resistant line of Plasmodium berghei ANKA and N strain].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Drug Resistance, Microbial; Malaria; Male; Mice; Plasmodium berghei; Primaquine; Pyrans; Sesquiterpenes | 1986 |
The chemotherapy of rodent malaria, XL. The action of artemisinin and related sesquiterpenes.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Resistance; Malaria; Male; Mice; Pigments, Biological; Plasmodium berghei; Pyrans; Sesquiterpenes | 1986 |
[Studies on the pharmacokinetics of qinghaosu and two of its active derivatives in dogs].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Dogs; Kinetics; Male; Pyrans; Sesquiterpenes | 1986 |
Clinical studies on treatment of cerebral malaria with qinghaosu and its derivatives.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Brain Diseases; Child; Child, Preschool; Female; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum; Sesquiterpenes | 1982 |
Effects of qinghaosu (artemisinin) and its derivatives on experimental cutaneous leishmaniasis.
Topics: Animals; Artemether; Artemisinins; Artesunate; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Leishmania; Leishmaniasis, Cutaneous; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Sesquiterpenes; Time Factors | 1993 |
Antimalarial drugs reduce cytoadherence and rosetting Plasmodium falciparum.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Cell Adhesion; Erythrocytes; Humans; In Vitro Techniques; Malaria, Falciparum; Middle Aged; Phenanthrenes; Plasmodium falciparum; Quinine; Rosette Formation; Sesquiterpenes | 1996 |
In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs.
Topics: Adult; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Drug Evaluation, Preclinical; Drug Resistance; Humans; In Vitro Techniques; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Quinine; Sesquiterpenes | 1996 |
Assessment of the neurotoxicity of parenteral artemisinin derivatives in mice.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Behavior, Animal; Body Weight; Brain Stem; Female; Injections, Intramuscular; Mice; Sesquiterpenes | 1998 |
A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Audiometry; Case-Control Studies; Child; Child, Preschool; Drug Resistance, Multiple; Drug Therapy, Combination; Evoked Potentials, Auditory, Brain Stem; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Thailand | 2000 |
Studies of the neurotoxicity of oral artemisinin derivatives in mice.
Topics: Administration, Oral; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Brain Stem; Drug Administration Schedule; Female; Injections, Intramuscular; Mice; Sesquiterpenes | 2000 |
Potent antimalarial activities of polyether antibiotic, X-206.
Topics: Actinomycetales; Animals; Anti-Bacterial Agents; Antimalarials; Artemether; Artemisinins; Artesunate; Cell Death; Cell Line; Chloroquine; Drug Resistance; Embryo, Mammalian; Embryo, Nonmammalian; Ethers, Cyclic; Humans; Malaria; Mice; Molecular Structure; Plasmodium berghei; Plasmodium falciparum; Pyrimethamine; Quinine; Sesquiterpenes | 2001 |
The development of new antimalarial drugs: qinghaosu and dihydro-qinghaosu.
Topics: Animals; Antimalarials; Artemether; Artemisia; Artemisinins; Artesunate; Drugs, Chinese Herbal; Humans; Sesquiterpenes | 1999 |
Authentication of artemether, artesunate and dihydroartemisinin antimalarial tablets using a simple colorimetric method.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Colorimetry; Diazonium Compounds; Sesquiterpenes; Tablets | 2001 |
mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Cell Line; Gene Expression Profiling; Humans; Oligonucleotide Array Sequence Analysis; RNA, Messenger; Sesquiterpenes; Transcription, Genetic; Tumor Cells, Cultured | 2002 |
Clinical experience with intravenous quinine, intramuscular artemether and intravenous artesunate for the treatment of severe malaria in Thailand.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Malaria, Falciparum; Male; Middle Aged; Prospective Studies; Quinine; Sesquiterpenes; Thailand; Treatment Outcome | 2003 |
Preparation of 10-trifluoromethyl artemether and artesunate. Influence of hexafluoropropan-2-ol on substitution reaction.
Topics: Alcohols; Antimalarials; Artemether; Artemisinins; Artesunate; Bromine; Carboxylic Acids; Hydrocarbons, Fluorinated; Methyl Chloride; Propanols; Sesquiterpenes | 2003 |
Fluoroartemisinin: trifluoromethyl analogues of artemether and artesunate.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Stability; Fluorine; Hydrolysis; Malaria; Mice; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes; Structure-Activity Relationship | 2004 |
[Efficacy of therapeutic combinations with artemisinin derivatives in the treatment of non complicated malaria in Burundi].
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Burundi; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Rural Health; Sesquiterpenes; Treatment Failure; Urban Health; Vomiting | 2004 |
The efficacies of artesunate-sulfadoxine-pyrimethamine and artemether-lumefantrine in the treatment of uncomplicated, Plasmodium falciparum malaria, in an area of low transmission in central Sudan.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Prospective Studies; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Outcome | 2006 |
Plasmodium vivax: in vitro susceptibility of blood stages to synthetic trioxolane compounds and the diamidine DB75.
Topics: Animals; Antimalarials; Aotidae; Artemether; Artemisinins; Artesunate; Benzamidines; Chloroquine; Drug Resistance; Heterocyclic Compounds, 1-Ring; Inhibitory Concentration 50; Malaria, Vivax; Parasitemia; Peroxides; Plasmodium falciparum; Plasmodium vivax; Sesquiterpenes; Spiro Compounds; Time Factors | 2006 |
Operational response to malaria epidemics: are rapid diagnostic tests cost-effective?
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Cost-Benefit Analysis; Diagnostic Tests, Routine; Disease Outbreaks; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Health Care Costs; Humans; Lumefantrine; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Sensitivity and Specificity; Sesquiterpenes | 2006 |
Artesunate and artemether are effective fasciolicides in the rat model and in vitro.
Topics: Animals; Antiplatyhelmintic Agents; Artemether; Artemisinins; Artesunate; Bile Ducts; Disease Models, Animal; Fasciola hepatica; Fascioliasis; Female; Microscopy, Electron, Scanning; Rats; Rats, Wistar; Sesquiterpenes | 2006 |
From chloroquine to artemisinin-based combination therapy: the Sudanese experience.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Health Policy; Humans; Lumefantrine; Malaria, Falciparum; Product Surveillance, Postmarketing; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Time Factors | 2006 |
Effect of artesunate and artemether against Clonorchis sinensis and Opisthorchis viverrini in rodent models.
Topics: Animals; Artemether; Artemisinins; Artesunate; Clonorchis sinensis; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Opisthorchis; Rats; Sesquiterpenes | 2006 |
Malaria treatment failures after artemisinin-based therapy in three expatriates: could improved manufacturer information help to decrease the risk of treatment failure?
Topics: Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Cote d'Ivoire; Dose-Response Relationship, Drug; Drug Labeling; Ethanolamines; Female; Fluorenes; Guidelines as Topic; Guinea; Humans; Lactones; Lumefantrine; Malaria, Falciparum; Parasitemia; Recurrence; Risk; Sesquiterpenes; Sudan; Switzerland; Treatment Failure; World Health Organization | 2006 |
Quality control of active ingredients in artemisinin-derivative antimalarials within Kenya and DR Congo.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Capsules; Chromatography, High Pressure Liquid; Democratic Republic of the Congo; Dosage Forms; Endemic Diseases; Humans; Kenya; Malaria, Falciparum; Quality Control; Sesquiterpenes; Tablets | 2007 |
[Extraction of artemisinin and synthesis of its derivates artesunate and artemether].
Topics: Artemether; Artemisinins; Artesunate; Chemistry, Pharmaceutical; Sesquiterpenes | 2006 |
In vitro assessment of artesunate, artemether and amodiaquine susceptibility and molecular analysis of putative resistance-associated mutations of Plasmodium falciparum from São Tomé and Príncipe.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Atlantic Islands; Child; Child, Preschool; Drug Resistance; Genes, Protozoan; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Sesquiterpenes | 2007 |
Fasciola hepatica: tegumental alterations in adult flukes following in vitro and in vivo administration of artesunate and artemether.
Topics: Administration, Oral; Animals; Antiplatyhelmintic Agents; Artemether; Artemisinins; Artesunate; Fasciola hepatica; Fascioliasis; Female; Microscopy, Electron, Scanning; Rats; Rats, Sprague-Dawley; Sesquiterpenes | 2008 |
Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Design; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Global Health; Half-Life; Humans; Lumefantrine; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Proguanil; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2007 |
Resistance to artemisinin derivatives along the Thai-Cambodian border.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Cambodia; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Sesquiterpenes; Thailand | 2007 |
Plasmodium falciparum from Pará state (Brazil) shows satisfactory in vitro response to artemisinin derivatives and absence of the S769N mutation in the SERCA-type PfATPase6.
Topics: Adenosine Triphosphatases; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Brazil; Drug Resistance; Gene Dosage; Humans; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Protozoan Proteins; Sesquiterpenes | 2008 |
Electronically stabilized versions of the antimalarial acetal trioxanes artemether and artesunate.
Topics: Administration, Oral; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Electrons; Mice; Molecular Conformation; Parasitic Sensitivity Tests; Stereoisomerism; Structure-Activity Relationship | 2008 |
Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children.
Topics: Africa; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Databases as Topic; Drug Combinations; Ethanolamines; Fluorenes; Genotype; Humans; Infant; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2008 |
Developmental toxicity of artesunate in the rat: comparison to other artemisinins, comparison of embryotoxicity and kinetics by oral and intravenous routes, and relationship to maternal reticulocyte count.
Topics: Administration, Oral; Animals; Artemether; Artemisinins; Artesunate; Cesarean Section; Drug Administration Routes; Embryo Loss; Embryo, Mammalian; Female; Fetus; Injections, Intravenous; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Reticulocyte Count; Reticulocytes | 2008 |
Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action.
Topics: Animals; Antineoplastic Agents; Artemether; Artemisinins; Artesunate; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Humans; Liver; Liver Neoplasms; Mice; Mice, Nude; Xenograft Model Antitumor Assays | 2008 |
[Effect of tribendimidine, artesunate, artemether and praziquantel, administered intragastrically at single, multiple or combined doses, to rats infected with Clonorchis sinensis].
Topics: Animals; Anthelmintics; Artemether; Artemisinins; Artesunate; Clonorchiasis; Clonorchis sinensis; Drug Therapy, Combination; Female; Male; Parasitic Sensitivity Tests; Phenylenediamines; Praziquantel; Random Allocation; Rats; Rats, Sprague-Dawley | 2008 |
Advances in global biotechnology and local resources to treat malaria.
Topics: Antimalarials; Artemether; Artemisia; Artemisinins; Artesunate; Drug Approval; Drug Resistance, Multiple; Drugs, Investigational; Global Health; Humans; Malaria; Minnesota; Phytotherapy | 2009 |
Combination chemotherapy against Clonorchis sinensis: experiments with artemether, artesunate, OZ78, praziquantel, and tribendimidine in a rat model.
Topics: Adamantane; Animals; Anthelmintics; Artemether; Artemisinins; Artesunate; Clonorchiasis; Clonorchis sinensis; Female; Phenylenediamines; Praziquantel; Rats; Rats, Wistar | 2009 |
Efficacy of artesunate and artemether against Clonorchis sinensis in rabbits.
Topics: Administration, Oral; Animals; Anthelmintics; Artemether; Artemisinins; Artesunate; Bile Ducts; Clonorchiasis; Clonorchis sinensis; Disease Models, Animal; Praziquantel; Rabbits | 2009 |
Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda.
Topics: Amodiaquine; Antimalarials; Area Under Curve; Artemether; Artemisinins; Artesunate; Biotransformation; Body Weight; Child; Child, Preschool; Chromatography, Liquid; Drug Combinations; Ethanolamines; Female; Fluorenes; Half-Life; Humans; Longitudinal Studies; Lumefantrine; Male; Spectrophotometry, Ultraviolet; Uganda | 2010 |
High performance liquid chromatographic evaluation of artemisinin, raw material in the synthesis of artesunate and artemether.
Topics: Artemether; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Magnetic Resonance Spectroscopy; Mass Spectrometry; Ultraviolet Rays | 2009 |
Effect of artemether, artesunate, OZ78, praziquantel, and tribendimidine alone or in combination chemotherapy on the tegument of Clonorchis sinensis.
Topics: Adamantane; Animals; Anthelmintics; Artemether; Artemisinins; Artesunate; Clonorchiasis; Clonorchis sinensis; Drug Therapy, Combination; Female; Microscopy, Electron, Scanning; Phenylenediamines; Praziquantel; Rats; Rats, Wistar; Skin; Treatment Outcome | 2010 |
Pyronaridine-artesunate for uncomplicated falciparum malaria.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Naphthyridines | 2010 |
Waking the sleeping beauty.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Humans; Malaria, Falciparum; Microbial Viability; Plasmodium falciparum; Recurrence | 2010 |
Effect of mefloquine administered orally at single, multiple, or combined with artemether, artesunate, or praziquantel in treatment of mice infected with Schistosoma japonicum.
Topics: Administration, Oral; Animals; Artemether; Artemisinins; Artesunate; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Mefloquine; Mice; Mice, Inbred Strains; Parasitic Diseases, Animal; Parasitic Sensitivity Tests; Praziquantel; Schistosoma japonicum; Schistosomiasis japonica; Schistosomicides; Treatment Outcome | 2011 |
The multiple-dosing pharmacokinetics of artemether, artesunate, and their metabolite dihydroartemisinin in rats.
Topics: Administration, Oral; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Male; Rats; Rats, Wistar | 2011 |
Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Brain; Leukocytes; Malaria, Cerebral; Mefloquine; Mice; Parasitemia; Plasmodium berghei; Quinine | 2011 |
Development and validation of a liquid chromatography and ion spray tandem mass spectrometry method for the quantification of artesunate, artemether and their major metabolites dihydroartemisinin and dihydroartemisinin-glucuronide in sheep plasma.
Topics: Animals; Artemether; Artemisinins; Artesunate; Calibration; Chromatography, Liquid; Chromatography, Reverse-Phase; Glucuronides; Logistic Models; Reproducibility of Results; Sensitivity and Specificity; Sheep; Tandem Mass Spectrometry | 2011 |
Automated erythrocytapheresis for severe falciparum malaria.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Australia; Automation; Blood Component Removal; Cambodia; Combined Modality Therapy; Drug Therapy, Combination; Erythrocyte Transfusion; Erythrocytes; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Parasitemia; Travel | 2011 |
Effects of artemether, artesunate and dihydroartemisinin administered orally at multiple doses or combination in treatment of mice infected with Schistosoma japonicum.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Artemether; Artemisinins; Artesunate; Disease Models, Animal; Female; Mice; Rodent Diseases; Schistosoma japonicum; Schistosomiasis japonica; Treatment Outcome | 2011 |
Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia.
Topics: Acute Kidney Injury; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Ethanolamines; Female; Fluorenes; Hospitals, Urban; Humans; Lumefantrine; Malaria; Malaysia; Microscopy; Middle Aged; Parasitemia; Patient Selection; Plasmodium knowlesi; Polymerase Chain Reaction; Quinine; Respiratory Distress Syndrome; Severity of Illness Index; Shock; Survival Rate | 2011 |
[In vitro effect of seven anthelmintic agents against adult Clonorchis sinensis].
Topics: Animals; Anthelmintics; Artemether; Artemisinins; Artesunate; Clonorchis sinensis; Levamisole; Mebendazole; Phenylenediamines; Praziquantel | 2011 |
Evaluation of the pharmacokinetic profile of artesunate, artemether and their metabolites in sheep naturally infected with Fasciola hepatica.
Topics: Amebicides; Animals; Anthelmintics; Area Under Curve; Artemether; Artemisinins; Artesunate; Chromatography, Liquid; Dose-Response Relationship, Drug; Fasciola hepatica; Fascioliasis; Half-Life; Microscopy, Electron, Scanning; Molecular Structure; Sheep; Sheep Diseases; Tandem Mass Spectrometry | 2012 |
Intravenous β-artemether formulation (ARM NLC) as a superior alternative to commercial artesunate formulation.
Topics: Administration, Intravenous; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Disease Models, Animal; Malaria; Male; Mice; Parasitemia; Plasmodium berghei; Treatment Outcome | 2012 |
New treatment policy of malaria as a part of malaria control program in Indonesia.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Disease Eradication; Drug Resistance; Drug Therapy, Combination; Health Policy; Humans; Indonesia; Malaria, Falciparum; Malaria, Vivax; Practice Guidelines as Topic; Primaquine | 2012 |
Substandard artemisinin-based antimalarial medicines in licensed retail pharmaceutical outlets in Ghana.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chemistry Techniques, Analytical; Drug and Narcotic Control; Drug Evaluation; Drug Industry; Ghana; Pharmaceutical Preparations; Pharmacies; Quality Control | 2012 |
Structural insights into the theoretical model of Plasmodium falciparum NADH dehydrogenase and its interaction with artemisinin and derivatives: towards global health therapeutics.
Topics: Amino Acid Sequence; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Design; Flavin-Adenine Dinucleotide; Global Health; Humans; Molecular Docking Simulation; Molecular Sequence Data; NADH Dehydrogenase; Plasmodium falciparum; Protein Binding; Protein Interaction Domains and Motifs; Protein Structure, Secondary; Protozoan Proteins; Sequence Homology, Amino Acid; Static Electricity; Thermodynamics; Tumor Protein, Translationally-Controlled 1 | 2013 |
Validation of ELISA for quantitation of artemisinin-based antimalarial drugs.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Confidence Intervals; Counterfeit Drugs; Enzyme-Linked Immunosorbent Assay | 2013 |
Efficacy of artemether and artesunate in mice infected with praziquantel non-susceptible isolate of Schistosoma japonicum.
Topics: Administration, Oral; Animals; Artemether; Artemisinins; Artesunate; Disease Models, Animal; Drug Resistance; Female; Mice; Mice, Inbred ICR; Praziquantel; Schistosoma japonicum; Schistosomiasis japonica; Schistosomicides | 2014 |
Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Evaluation, Preclinical; Drug Interactions; Humans; Inhibitory Concentration 50; Microsomes, Liver; Recombinant Proteins; Tandem Mass Spectrometry | 2014 |
Hemophagocytic syndrome associated with severe Plasmodium vivax malaria in a child in Bikaner (northwestern India).
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Biopsy, Needle; Bone Marrow; Child; Ethanolamines; Female; Fluorenes; Humans; India; Liver Function Tests; Lumefantrine; Lymphohistiocytosis, Hemophagocytic; Malaria, Vivax; Plasmodium vivax; Primaquine; Schizonts; Treatment Outcome | 2013 |
Subchronic toxicological study of two artemisinin derivatives in dogs.
Topics: Administration, Oral; Animals; Arrhythmias, Cardiac; Artemether; Artemisinins; Artesunate; Dogs; Erythrocyte Count; Erythropoiesis; Female; Hematopoiesis, Extramedullary; Injections, Intramuscular; Male; Microscopy, Electron, Transmission; Mitochondria; Toxicity Tests | 2014 |
Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.
Topics: Age Factors; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Female; Humans; Male; Models, Theoretical | 2014 |
[Therapeutic effect of 138 imported falciparum malaria patients].
Topics: Adult; Africa; Antimalarials; Artemether; Artemisinins; Artesunate; China; Diagnostic Errors; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Retrospective Studies; Travel; Young Adult | 2014 |
A comparative study on the impact of two artemisinin derivatives, artemether and artesunate, on the female reproductive system of Fasciola hepatica.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Fasciola hepatica; Female; Genitalia, Female; Ovum | 2015 |
NO-Donor Dihydroartemisinin Derivatives as Multitarget Agents for the Treatment of Cerebral Malaria.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chemistry Techniques, Synthetic; Malaria, Cerebral; Mice; Molecular Targeted Therapy; Muscle Relaxation; Nitric Oxide Donors; Plasmodium berghei; Rats; Vasodilator Agents | 2015 |
Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells.
Topics: Apoptosis; Artemether; Artemisinins; Artesunate; Cell Death; Cell Line, Tumor; Cyclohexylamines; Deferoxamine; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Iron; Molecular Structure; Oligonucleotide Array Sequence Analysis; Phenylenediamines | 2015 |
Genetic Transformation of Artemisia carvifolia Buch with rol Genes Enhances Artemisinin Accumulation.
Topics: Agrobacterium tumefaciens; Antimalarials; Artemether; Artemisia annua; Artemisinins; Artesunate; Base Sequence; Biosynthetic Pathways; Gene Expression Regulation, Plant; Molecular Sequence Data; Plant Proteins; Plants, Genetically Modified; Transformation, Genetic; Trichomes | 2015 |
Disruption of spermatogenesis in the liver fluke, Fasciola hepatica by two artemisinin derivatives, artemether and artesunate.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Apoptosis; Artemether; Artemisinins; Artesunate; Cell Count; Cell Survival; Disease Models, Animal; Fasciola hepatica; Fascioliasis; Histocytochemistry; Male; Microscopy, Electron, Transmission; Mitochondria; Rats; Spermatogenesis; Spermatozoa; Time Factors | 2017 |
Straightforward conversion of decoquinate into inexpensive tractable new derivatives with significant antimalarial activities.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Decoquinate; Drug Resistance, Multiple; Emetine; Humans; Inhibitory Concentration 50; Plasmodium falciparum; Quinolones | 2016 |
Health worker and policy-maker perspectives on use of intramuscular artesunate for pre-referral and definitive treatment of severe malaria at health posts in Ethiopia.
Topics: Administrative Personnel; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Ethiopia; Female; Health Personnel; Humans; Injections, Intramuscular; Interviews as Topic; Malaria; Male; Quinine; Young Adult | 2016 |
Impact of Extended Duration of Artesunate Treatment on Parasitological Outcome in a Cytocidal Murine Malaria Model.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Disease Models, Animal; Female; Malaria; Mice; Mice, Inbred BALB C; Quinolines | 2017 |
Efficacy of artesunate + sulphadoxine/pyrimethamine and artemether + lumefantrine and dhfr and dhps mutations in Somalia: evidence for updating the malaria treatment policy.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Dihydropteroate Synthase; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Mutation; Plasmodium falciparum; Prospective Studies; Protozoan Proteins; Pyrimethamine; Somalia; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2017 |
Severe delayed haemolytic anaemia associated with artemether-lumefantrine treatment of malaria in a Japanese traveller.
Topics: Administration, Intravenous; Administration, Oral; Anemia, Hemolytic; Antimalarials; Artemether; Artemisinins; Artesunate; Blackwater Fever; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Plasmodium vivax; Recurrence; Young Adult | 2018 |
Absence of
Topics: Antimalarials; Artemether; Artesunate; Brazil; Drug Combinations; Drug Resistance; Epidemiological Monitoring; Gene Expression; Genetic Markers; Genotyping Techniques; Humans; Kelch Repeat; Malaria, Falciparum; Mefloquine; Molecular Epidemiology; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinine | 2018 |
Assessing the consistency assumptions underlying network meta-regression using aggregate data.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Bayes Theorem; Data Interpretation, Statistical; Humans; Malaria; Models, Statistical; Network Meta-Analysis; Odds Ratio; Quinine; Regression Analysis; Reproducibility of Results; Research Design | 2019 |
Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine.
Topics: Adult; Amodiaquine; Antimalarials; Artemether; Artesunate; Breast Feeding; Cross-Over Studies; Drug Interactions; Female; Heterocyclic Compounds, 3-Ring; Humans; Lumefantrine; Male; Oxazines; Piperazines; Pyridones | 2019 |
Interpretation of Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Drug Interactions; Heterocyclic Compounds, 3-Ring; Oxazines; Piperazines; Pyridones | 2019 |
Reply to Banda et al., "Interpretation of Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine".
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Drug Interactions; Heterocyclic Compounds, 3-Ring; Oxazines; Piperazines; Pyridones | 2019 |
Evolution of Plasmodium falciparum drug resistance genes following artemisinin combination therapy in Sudan.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; DNA, Protozoan; Drug Resistance; Drug Therapy, Combination; Genetic Markers; Genotype; Humans; Lumefantrine; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sudan; Sulfadoxine | 2019 |
Adherence to antimalarial drug policy among doctors in Delta State, Nigeria: implications for malaria control.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Chloroquine; Drug Resistance, Microbial; Female; Guideline Adherence; Health Policy; Humans; Malaria, Falciparum; Male; Middle Aged; Nigeria; Plasmodium falciparum; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quinine; Surveys and Questionnaires; Young Adult | 2019 |
Safety and tolerability of artesunate-amodiaquine, artemether-lumefantrine and quinine plus clindamycin in the treatment of uncomplicated Plasmodium falciparum malaria in Kinshasa, the Democratic Republic of the Congo.
Topics: Amodiaquine; Anti-Bacterial Agents; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child, Preschool; Clindamycin; Democratic Republic of the Congo; Drug Combinations; Female; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Quinine | 2019 |
Antimalarial combination therapies increase gastric ulcers through an imbalance of basic antioxidative-oxidative enzymes in male Wistar rats.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artesunate; Drug Therapy, Combination; Gastric Mucosa; Glutathione; Indomethacin; Inflammation; Lumefantrine; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Stomach Ulcer | 2020 |
Leishmania amazonensis response to artemisinin and derivatives.
Topics: Animals; Artemether; Artemisinins; Artesunate; Disease Models, Animal; Female; Leishmania mexicana; Mice; Mice, Inbred BALB C; Parasite Load; Trypanocidal Agents | 2021 |
Dolutegravir pharmacokinetics during co-administration with either artemether/lumefantrine or artesunate/amodiaquine.
Topics: Africa; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Drug Combinations; Ethanolamines; Fluorenes; Heterocyclic Compounds, 3-Ring; Humans; Malaria, Falciparum; Oxazines; Piperazines; Pyridones | 2021 |
Malaria in an asylum seeker paediatric liver transplant recipient: diagnostic challenges for migrant population.
Topics: Antimalarials; Artemether; Artesunate; Child, Preschool; Humans; Liver Transplantation; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Transients and Migrants; Transplant Recipients; Treatment Outcome | 2021 |
Artemether, Artesunate, Arteannuin B, Echinatin, Licochalcone B and Andrographolide Effectively Inhibit SARS-CoV-2 and Related Viruses
Topics: Artemether; Artemisinins; Artesunate; Chalcones; COVID-19; Diterpenes; Humans; SARS-CoV-2 | 2021 |
Molecular Basis of Artemisinin Derivatives Inhibition of Myeloid Differentiation Protein 2 by Combined in Silico and Experimental Study.
Topics: Animals; Anti-Inflammatory Agents; Artemether; Artemisinins; Artesunate; Binding Sites; Cell Line; Cell Survival; Fatty Acid-Binding Proteins; Hydrophobic and Hydrophilic Interactions; Immunomodulation; In Vitro Techniques; Lipopolysaccharides; Lymphocyte Antigen 96; Mice; Microglia; Molecular Docking Simulation; Molecular Dynamics Simulation; Nitric Oxide; Protein Binding; Thermodynamics; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2021 |
Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Chloroquine; DNA Copy Number Variations; Female; Humans; Liberia; Malaria; Malaria, Falciparum; Membrane Transport Proteins; Plasmodium falciparum; Pregnancy | 2022 |
Prevalence of malaria among febrile patients and assessment of efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated malaria in Dolisie, Republic of the Congo.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Congo; Drug Combinations; Fever; Humans; Malaria; Parasitemia; Prevalence | 2022 |
Stakeholder perceptions on the deployment of multiple first-line therapies for uncomplicated malaria: a qualitative study in the health district of Kaya, Burkina Faso.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Burkina Faso; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Naphthyridines | 2022 |
Exploring the Potential Mechanism of Artemisinin and Its Derivatives in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking.
Topics: Artemether; Artemisinins; Artesunate; Caspase 3; Drugs, Chinese Herbal; ErbB Receptors; Humans; Interleukin-17; Mitogen-Activated Protein Kinase 14; Molecular Docking Simulation; Network Pharmacology; Osteoporosis; Prolactin | 2022 |
Return to Travel in the Coronavirus Disease 2019 Pandemic Recovery Period and Implications for Imported Malaria: Reinforcing Prevention, Early Diagnosis, and Appropriate Treatment of Malaria.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; COVID-19; COVID-19 Testing; Early Diagnosis; Humans; Malaria; Malaria, Falciparum; Pandemics; Travel; United States | 2023 |
Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Chad: clinical and genetic surveillance.
Topics: Adult; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Chad; Female; Humans; Malaria, Falciparum; Pregnancy; Prospective Studies | 2023 |